Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

BMP4-related anomalies can cause a wide range of eye, brain, and hand/foot problems, and new cases show this variability.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Anionic surfactants significantly improve the foaming of minoxidil gel shampoo.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Keratin from hair binds well to gold and BMP-2, useful for bone repair.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.